QOF

Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents

Product code

QOF

Device name

Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents

Device class

Class 2

21 CFR

21 CFR 866.3981

Medical specialty

Microbiology

Marketing pathway

510(K)

510(k) clearances (last 3 years)

25

Summaries archived here

21 (direct download)

510(k) clearances (all years, FDA)

33 (all years; only the last 3 years are listed here)

FDA classification definition

A device to detect and identify nucleic acid targets in respiratory specimens from microbial agents that cause the SARS-CoV-2 respiratory infection and other microbial agents when in a multi-target test is an in vitro diagnostic device intended for the detection and identification of SARS-CoV-2 and other microbial agents when in a multi-target test in human clinical respiratory specimens from patients suspected of respiratory infection who are at risk for exposure or who may have been exposed to these agents. The device is intended to aid in the diagnosis of respiratory infection in conjunction with other clinical, epidemiologic, and laboratory data or other risk factors.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (25)

Last three years. Most recent: 2026-06-12.

21 summaries are archived here for direct download.